Poplar Forest Capital Decreased By $21.60 Million Its Te Connectivity LTD (TEL) Position; Ghost Tree Capital Has Lowered By $1.30 Million Its Clovis Oncology (CLVS) Position

June 17, 2018 - By Ash

TE Connectivity Ltd. (NYSE:TEL) Logo

Poplar Forest Capital Llc decreased Te Connectivity Ltd (TEL) stake by 54.15% reported in 2018Q1 SEC filing. Poplar Forest Capital Llc sold 218,169 shares as Te Connectivity Ltd (TEL)’s stock declined 9.88%. The Poplar Forest Capital Llc holds 184,755 shares with $18.46 million value, down from 402,924 last quarter. Te Connectivity Ltd now has $34.66 billion valuation. The stock decreased 0.31% or $0.31 during the last trading session, reaching $99. About 1.68 million shares traded or 0.56% up from the average. TE Connectivity Ltd. (NYSE:TEL) has risen 20.40% since June 17, 2017 and is uptrending. It has outperformed by 7.83% the S&P500. Some Historical TEL News: ; 20/03/2018 – TE CONNECTIVITY LTD TEL.N : MELIUS RESEARCH STARTS WITH OVERWEIGHT; TARGET PRICE $135; 30/05/2018 – Mouser Electronics Named Global High Service Distributor of the Year by TE Connectivity; 20/03/2018 – TE Connectivity exhibits data and power connectivity solutions at OCP Summit 2018; 25/04/2018 – TE Connectivity Sees 3Q Adj EPS $1.35-Adj EPS $1.37; 14/05/2018 – nVent Electric plc to Participate in the Electrical Products Group Conference; 18/03/2018 – TE Connectivity Presents Heilind Asia with Asia Pacific 2017 Content Per Customer Award; 09/05/2018 – TE CONNECTIVITY BOOSTS QTR DIV TO 44C/SHR FROM 40C, EST. 42C; 20/03/2018 – TE Connectivity introduces 48V bus bar connectors and cable assemblies at the 2018 OCP Summit; 16/05/2018 – TE Connectivity at AllianceBernstein Conference May 31; 16/03/2018 – TE Connectivity May Benefit, Industry Posts 32nd Straight Gain

Ghost Tree Capital Llc decreased Clovis Oncology Inc (CLVS) stake by 25% reported in 2018Q1 SEC filing. Ghost Tree Capital Llc sold 25,000 shares as Clovis Oncology Inc (CLVS)’s stock declined 12.39%. The Ghost Tree Capital Llc holds 75,000 shares with $3.96M value, down from 100,000 last quarter. Clovis Oncology Inc now has $2.39B valuation. The stock increased 1.18% or $0.53 during the last trading session, reaching $45.56. About 960,036 shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has declined 11.65% since June 17, 2017 and is downtrending. It has underperformed by 24.22% the S&P500. Some Historical CLVS News: ; 23/03/2018 – CLOVIS SAYS CHMP GRANTS POSITIVE OPINION FOR RUBRACA TABLETS; 06/04/2018 – CLOVIS WINS FDA APPROVAL FOR EXPANDED USE OF RUBRACA; 23/03/2018 – CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca┬« (rucaparib) Tablets; 23/03/2018 – CHMP RECOMMENDS CONDITIONAL MARKETING AUTHORISATION FOR RUBRACA; 23/03/2018 – CLOVIS ONCOLOGY BEGINS EARLY ACCESS PROGRAM FOR RUCAPARIB; 08/03/2018 – CLVS NOTICE OF ALLOWANCE FOR RUCAPARIB HIGH DOSAGE STRENGTH; 08/05/2018 – ASTRAZENECA AZN EMA OKS LYNPARZA: MAINTENANCE OVARIAN CANCER; 08/05/2018 – ASTRAZENECA PLC AZN.L – EUROPEAN MEDICINES AGENCY (EMA) HAS APPROVED LYNPARZA (OLAPARIB) TABLETS; 15/04/2018 – ASTRAZENECA, MERCK & CO.: LYNPARZA MEDIAN SURVIVAL 19.3 MONTHS; 08/05/2018 – MERCK – EMA APPROVED LYNPARZA TABLETS (300 MG TWICE DAILY) FOR USE AS A MAINTENANCE THERAPY WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. Clovis Oncology had 65 analyst reports since September 10, 2015 according to SRatingsIntel. Credit Suisse maintained the stock with “Buy” rating in Tuesday, July 18 report. The firm earned “Hold” rating on Monday, May 9 by WallachBeth Capital. J.P. Morgan maintained it with “Buy” rating and $7200 target in Thursday, June 1 report. The firm has “Buy” rating given on Tuesday, February 27 by Stifel Nicolaus. Bank of America initiated Clovis Oncology, Inc. (NASDAQ:CLVS) on Friday, January 27 with “Buy” rating. The rating was maintained by Barclays Capital with “Overweight” on Tuesday, February 27. On Wednesday, August 24 the stock rating was maintained by SunTrust with “Buy”. Piper Jaffray reinitiated Clovis Oncology, Inc. (NASDAQ:CLVS) on Monday, April 4 with “Neutral” rating. RBC Capital Markets maintained Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Friday, March 23. RBC Capital Markets has “Buy” rating and $7300 target. The stock of Clovis Oncology, Inc. (NASDAQ:CLVS) earned “Buy” rating by Stifel Nicolaus on Monday, January 23.

More recent Clovis Oncology, Inc. (NASDAQ:CLVS) news were published by: Seekingalpha.com which released: “Applied Materials Has Been Overly Punished – Cramer’s Lightning Round (5/29/18)” on May 30, 2018. Also Fool.com published the news titled: “Why Fossil Group, Companhia Siderurgica Nacional, and Immunomedics Jumped Today” on June 04, 2018. Nasdaq.com‘s news article titled: “Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in …” with publication date: June 04, 2018 was also an interesting one.

Analysts await Clovis Oncology, Inc. (NASDAQ:CLVS) to report earnings on August, 1. They expect $-1.27 EPS, up 1.55% or $0.02 from last year’s $-1.29 per share. After $-1.54 actual EPS reported by Clovis Oncology, Inc. for the previous quarter, Wall Street now forecasts -17.53% EPS growth.

Since January 8, 2018, it had 0 buys, and 6 insider sales for $1.45 million activity. SPICKSCHEN THORLEF sold $292,365 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) on Monday, January 8. 3,000 shares were sold by IVERS-READ GILLIAN C, worth $162,270.

Investors sentiment is 1.05 in 2018 Q1. Its the same as in 2017Q4. It is without change, as 27 investors sold CLVS shares while 65 reduced holdings. only 27 funds opened positions while 70 raised stakes. 48.28 million shares or 1.64% less from 49.09 million shares in 2017Q4 were reported. Pictet Asset has 333,930 shares for 0.04% of their portfolio. Greenwood Cap Associates Ltd Liability Company holds 5,573 shares. Rock Springs Cap Mgmt Lp holds 0.52% in Clovis Oncology, Inc. (NASDAQ:CLVS) or 231,500 shares. Invesco Ltd owns 347,086 shares or 0.01% of their US portfolio. Moore Cap Management Ltd Partnership holds 25,000 shares or 0.03% of its portfolio. Manufacturers Life Insur The accumulated 0% or 32,618 shares. Gabelli Funds Limited Liability Com has invested 0.01% in Clovis Oncology, Inc. (NASDAQ:CLVS). Fmr Ltd Com reported 1.37 million shares. Tocqueville Asset Management LP invested 0.03% in Clovis Oncology, Inc. (NASDAQ:CLVS). Kingdon Cap Management Limited Com holds 0.9% in Clovis Oncology, Inc. (NASDAQ:CLVS) or 216,024 shares. Metropolitan Life Co holds 0% or 14,339 shares. Rice Hall James Associate Limited Liability Corp invested in 0.31% or 148,079 shares. Ubs Asset Management Americas accumulated 420,105 shares or 0% of the stock. Mufg Americas reported 401 shares. University Of Notre Dame Du Lac accumulated 43,761 shares or 0.43% of the stock.

Analysts await TE Connectivity Ltd. (NYSE:TEL) to report earnings on July, 25. They expect $1.37 EPS, up 10.48% or $0.13 from last year’s $1.24 per share. TEL’s profit will be $479.69M for 18.07 P/E if the $1.37 EPS becomes a reality. After $1.42 actual EPS reported by TE Connectivity Ltd. for the previous quarter, Wall Street now forecasts -3.52% negative EPS growth.

Among 13 analysts covering TE Connectivity (NYSE:TEL), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. TE Connectivity had 49 analyst reports since July 23, 2015 according to SRatingsIntel. Citigroup maintained TE Connectivity Ltd. (NYSE:TEL) rating on Thursday, January 25. Citigroup has “Buy” rating and $119 target. Robert W. Baird maintained the shares of TEL in report on Wednesday, January 24 with “Buy” rating. The firm has “Neutral” rating by Longbow given on Thursday, January 14. The firm has “Hold” rating given on Wednesday, March 2 by Berenberg. The firm has “Buy” rating by Cowen & Co given on Wednesday, August 9. On Monday, September 4 the stock rating was maintained by Stifel Nicolaus with “Buy”. RBC Capital Markets maintained the stock with “Buy” rating in Wednesday, January 3 report. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, April 26. Cowen & Co maintained the shares of TEL in report on Friday, September 15 with “Buy” rating. On Thursday, January 25 the stock rating was maintained by Morgan Stanley with “Overweight”.

Poplar Forest Capital Llc increased Davita Inc (NYSE:DVA) stake by 12,396 shares to 63,656 valued at $4.20M in 2018Q1. It also upped Advance Auto Parts Inc (NYSE:AAP) stake by 228,767 shares and now owns 379,892 shares. American Intl Group Inc (NYSE:AIG) was raised too.

Another recent and important TE Connectivity Ltd. (NYSE:TEL) news was published by Globenewswire.com which published an article titled: “Market Trends Toward New Normal in TE Connectivity, Nutrien, Cheetah Mobile, Unilever NV, B2Gold, and Piedmont …” on June 08, 2018.

Investors sentiment decreased to 0.82 in 2018 Q1. Its down 0.20, from 1.02 in 2017Q4. It worsened, as 50 investors sold TEL shares while 229 reduced holdings. 71 funds opened positions while 159 raised stakes. 309.75 million shares or 2.21% more from 303.06 million shares in 2017Q4 were reported. Linscomb Williams holds 2,805 shares or 0.02% of its portfolio. Comerica State Bank owns 245,186 shares or 0.18% of their US portfolio. Dana Advsr reported 1.71% in TE Connectivity Ltd. (NYSE:TEL). Amica Pension Fund Board Of Trustees stated it has 0.14% of its portfolio in TE Connectivity Ltd. (NYSE:TEL). Factory Mutual stated it has 0.24% of its portfolio in TE Connectivity Ltd. (NYSE:TEL). Northeast Consultants Incorporated holds 0.28% or 8,329 shares in its portfolio. Shine Advisory reported 75 shares. Huber Capital Ltd Limited Liability Company invested in 0.34% or 58,095 shares. Commerzbank Aktiengesellschaft Fi reported 10,077 shares stake. Stratos Wealth, a Ohio-based fund reported 3,930 shares. Teachers Retirement Sys Of The State Of Kentucky stated it has 0.35% in TE Connectivity Ltd. (NYSE:TEL). Amica Mutual Insur has invested 0.14% of its portfolio in TE Connectivity Ltd. (NYSE:TEL). Hl Fin Svcs Ltd Liability reported 2.5% of its portfolio in TE Connectivity Ltd. (NYSE:TEL). Advisory Services Networks Lc stated it has 2,277 shares or 0.02% of all its holdings. Moreover, Td Asset Mgmt has 0.02% invested in TE Connectivity Ltd. (NYSE:TEL) for 117,674 shares.

Clovis Oncology, Inc. (NASDAQ:CLVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>